ConductScience.org, home

Paper19005182

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.

Rodeghiero F and 19 others. Blood, 2009. Cited by 2,070 papers, by iCite.

Cite this record

ConductScience Library. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Papers, record 19005182. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19005182

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.
PubMed
Journal
Blood
PubMed
Year
2009
PubMed
Publication types
Consensus Statement, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
2,070
iCite
Relative citation ratio, by iCite
59.8
iCite
Revised in PubMed
2026-01-28
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rodeghiero FFrancesco
2Stasi RRoberto
3Gernsheimer TTerry
4Michel MMarc
5Provan DDrew
6Arnold DMDonald M
7Bussel JBJames B
8Cines DBDouglas B
9Chong BHBeng H
10Cooper NNichola
11Godeau BBertrand
12Lechner KKlaus
13Mazzucconi MGMaria Gabriella
14McMillan RRobert
15Sanz MAMiguel A
16Imbach PPaul
17Blanchette VVictor
18Kühne TThomas
19Ruggeri MMarco
20George JNJames N

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Purpura, Thrombocytopenic, IdiopathicMajor topic
Terminology as TopicMajor topic
Health Planning Guidelines
Humans
International Cooperation
Reference Standards
Treatment Outcome

Source PubMed

Download CSV of topics

Trials26

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT01356511High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)BackgroundClinicalTrials.gov
NCT01506414Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP)BackgroundClinicalTrials.gov
NCT01525836rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITPBackgroundClinicalTrials.gov
NCT01667263The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune ThrombocytopeniaBackgroundClinicalTrials.gov
NCT01727999Genome-Wide Gene Expression Profiling of Patients With ITP Receiving Thrombopoietin MimeticsBackgroundClinicalTrials.gov
NCT01734044rhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITPResultsClinicalTrials.gov
NCT01734057Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)ResultsClinicalTrials.gov
NCT01965626A Multicenter Randomized Open-label Study of Oseltamivir Combined With HD-DEX Versus HD-DEX in the Management of ITPResultsClinicalTrials.gov
NCT02153060An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP)BackgroundClinicalTrials.gov
NCT02834468DEX Combined With RTX, CSA and IVIG in the Management of Newly Diagnosed ITP PatientsBackgroundClinicalTrials.gov
NCT02892630Immune Thrombocytopenia in PregnancyBackgroundClinicalTrials.gov
NCT02914054Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With DexamethasoneBackgroundClinicalTrials.gov
NCT03252457Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITPResultsClinicalTrials.gov
NCT03412188The Effect of Eltrombopag on the Expression of Platelet Collagen Receptor GPVI in Pediatric ITP.ResultsClinicalTrials.gov
NCT03754634A Prospective, Open, Multicenter Clinical Trial of Eltrombopag Combined With Diacerein in Eltrombopag-inefficient or Relapsed ITPResultsClinicalTrials.gov
NCT03771378Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP)ResultsClinicalTrials.gov
NCT04113915Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple TherapyBackgroundClinicalTrials.gov
NCT04128358Triple Therapy in Patients With Idiopathic Thrombocytopenic Purpura : What is Behind?BackgroundClinicalTrials.gov
NCT04917679Eltrombopag Plus Diacerein vs Eltrombopag in Adult ITPBackgroundClinicalTrials.gov
NCT05411874A Multicenter Randomized Open-label Study of Chidamide Plus HD-DEX Versus HD-DEX in ITPBackgroundClinicalTrials.gov

See all 26 trialsDownload CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in19713486Antinuclear antibody (ANA)-positive thrombocytopenia: primary, but with a difference.https://conductscience.org/library/papers/19713486

Source PubMed

Download CSV of comments and corrections

Cited by963

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,070 citations.

PMIDTitleJournalYearIn PapersSource
42967207Immune Thrombocytopenia Following COVID-19 Vaccination in a Pediatric Patient.Cureus2026https://conductscience.org/library/papers/42967207PubMed
42945908
Update of the Brazilian Clinical Practice Guideline for primary immune thrombocytopenia: methodological process and main changes for diagnosis and treatment in the Brazilian Unified Health System (SUS).
Hematol Transfus Cell Ther2026https://conductscience.org/library/papers/42945908PubMed
42936669Severe Immune Thrombocytopenia Associated With Newly Diagnosed Rheumatoid Arthritis and Complicated by a Spontaneous Presacral Haematoma: A Case Report.Cureus2026https://conductscience.org/library/papers/42936669PubMed
42927077Treatment patterns and safety outcomes after splenectomy or thrombopoietin receptor agonists as second-line therapy for immune thrombocytopenia: Korean claims-based study.Res Pract Thromb Haemost2026https://conductscience.org/library/papers/42927077PubMed
42907786Initial response and long-term prognostic risk factors in pediatric ITP.BMC Pediatr2026https://conductscience.org/library/papers/42907786PubMed
42867565β2-adrenergic receptor agonist regulates macrophage polarization via HMGB1 in immune thrombocytopenia.Sci China Life Sci2026https://conductscience.org/library/papers/42867565PubMed
42866340Thrombocytopenia: from physiological homeostasis imbalance to mechanism-driven precision diagnosis and therapy.Front Immunol2026https://conductscience.org/library/papers/42866340PubMed
42866218The prediction of disease chronicity when immune thrombocytopenia is first diagnosed.Transl Pediatr2026https://conductscience.org/library/papers/42866218PubMed
42821196Unveiling the role of circulating monocyte-macrophage polarization state and PD-L1/PD-L2 expression in newly diagnosed pediatric ITP.Blood Res2026https://conductscience.org/library/papers/42821196PubMed
42780154
Long-term outcomes of eltrombopag plus cyclosporine A in eltrombopag-exposed patients with glucocorticoid-resistant or -dependent primary immune thrombocytopenia: a prospective, multicenter, single-arm, phase II study with extended follow-up.
Front Immunol2026https://conductscience.org/library/papers/42780154PubMed
42780051Artificial intelligence prediction of therapy response in newly diagnosed adult severe primary immune thrombocytopenia.Res Pract Thromb Haemost2026https://conductscience.org/library/papers/42780051PubMed
42761734
Longitudinal Divergence Between CONUT and GNRI Following Decreased Food Intake Temporally Associated With Trimethoprim-Sulfamethoxazole Administration in an Older Patient With Immune Thrombocytopenia and Dementia: A Case Report.
Cureus2026https://conductscience.org/library/papers/42761734PubMed
42751632Cytomegalovirus-Associated Thrombocytopenia in an Immunocompetent Infant: A Case Report.Pediatric Health Med Ther2026https://conductscience.org/library/papers/42751632PubMed
42730410Evolving Paradigms in the Management of Primary Immune Thrombocytopenia in Adults: From Corticosteroids to Targeted Therapies.Mediterr J Hematol Infect Dis2026https://conductscience.org/library/papers/42730410PubMed
42713481Diagnostic Utility of Platelet Indices in Differentiating Hypoproductive and Hyperdestructive Thrombocytopenia: A Cross-Sectional Study From North India.Cureus2026https://conductscience.org/library/papers/42713481PubMed
42707190Cost-effectiveness analysis of eltrombopag, hetrombopag and romiplostim for second-line treatment of primary immune thrombocytopenia in China.Front Med (Lausanne)2026https://conductscience.org/library/papers/42707190PubMed
42698986Dual Autoimmunity: Evans Syndrome and Multiple Sclerosis.Cureus2026https://conductscience.org/library/papers/42698986PubMed
42678489Early Use of Fostamatinib in Immune Thrombocytopenia.Adv Ther2026https://conductscience.org/library/papers/42678489PubMed
42675186Redefining neonatal thrombocytopenia: an evidence-based approach, improved by the refineR algorithm.J Perinatol2026https://conductscience.org/library/papers/42675186PubMed
42662888Avatrombopag in thrombopoietin receptor agonist-naïve patients with immune thrombocytopenia: real-world treatment patterns and clinical outcomes from the REAL-AVA 3.0 study.Res Pract Thromb Haemost2026https://conductscience.org/library/papers/42662888PubMed

See all 963 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
KRT2054474PubTator's text mininghttps://conductscience.org/library/genes/54474NCBI Gene
MPL4352PubTator's text mininghttps://conductscience.org/library/genes/4352NCBI Gene

Download CSV of genes

Drugs10

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
DECITABINECHEMBL1201129Results1https://conductscience.org/library/drugs/CHEMBL1201129ChEMBL
RITUXIMABCHEMBL1201576Results2https://conductscience.org/library/drugs/CHEMBL1201576ChEMBL
ROMIPLOSTIMCHEMBL1201832Results1https://conductscience.org/library/drugs/CHEMBL1201832ChEMBL
OSELTAMIVIRCHEMBL1229Results1https://conductscience.org/library/drugs/CHEMBL1229ChEMBL
AVATROMBOPAGCHEMBL2103883Results1https://conductscience.org/library/drugs/CHEMBL2103883ChEMBL
DEXAMETHASONECHEMBL384467Results3https://conductscience.org/library/drugs/CHEMBL384467ChEMBL
DIACEREINCHEMBL41286Results1https://conductscience.org/library/drugs/CHEMBL41286ChEMBL
RAFUTROMBOPAGCHEMBL4594401Results1https://conductscience.org/library/drugs/CHEMBL4594401ChEMBL
ELTROMBOPAGCHEMBL461101Results4https://conductscience.org/library/drugs/CHEMBL461101ChEMBL
RECOMBINANT HUMAN THROMBOPOIETINCHEMBL4802180Results3https://conductscience.org/library/drugs/CHEMBL4802180ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19005182

GET https://conductscience.org/api/papers/v1/19005182/trials?page=2